A study published in Nutrients investigated the effects of resveratrol and vitamin C on oxidative stress in postmenopausal women. The randomized controlled trial aimed at assessing how these supplements might help mitigate the oxidative damage that often follows menopause, a critical phase characterized by hormonal changes and diminished antioxidant capacity.
Menopausal Transition and Oxidative Stress
As women transition into menopause, there is a notable decline in antioxidant defense, leading to an increase in oxidative stress (OS). The study highlighted that around 15% of women in Mexico, where the research was conducted, have reached postmenopausal status, a figure expected to rise with increased life expectancy. Oxidative stress poses significant risks as it allows reactive oxidizing agents to damage vital cellular components, including lipids and proteins.
Prior findings indicate that postmenopausal women exhibit higher concentrations of oxidative stress markers compared to their reproductive counterparts [1]. This has led researchers to explore antioxidant supplementation as a potential strategy to counteract the negative effects of oxidative damage.
Rationale for Supplementary Treatment
The selection of resveratrol and vitamin C for this study was grounded in their established cardioprotective, anti-inflammatory, and antioxidant properties [2]. Resveratrol, a natural phytoestrogen, is associated with the enhancement of antioxidant enzymes while concomitantly reducing oxidative load [3]–[5]. Vitamin C is widely regarded for its role in protecting cells from oxidative damage and sustaining physiological functions.
Clinical Trial Overview
The analysis involved a pilot randomized, double-blind clinical trial that recruited women aged between 50 and 60 years in the early postmenopausal stage with insulin resistance. Key exclusion criteria included:
- Recent use of hormone replacement therapy
- Anticoagulant medications
- Antioxidant supplements
- Active smoking status
- Pre-existing health conditions
The study categorized participants into three groups:
- Group A: 13 women receiving resveratrol plus a vitamin C placebo.
- Group B: 15 women receiving a combination of resveratrol and vitamin C.
- Group C: 14 women receiving vitamin C plus a resveratrol placebo.
Each group was administered specified dosages of resveratrol and vitamin C for a period of three months, after which changes in oxidative stress markers were evaluated.
Findings on Oxidative Stress
Initial comparisons of clinical and biochemical blood tests showed no significant differences in parameters such as weight, BMI, glucose, insulin, and lipid profiles post-treatment. However, nominal changes were observed:
| Group | Total Cholesterol Change | Triglyceride Change |
|---|---|---|
| Vitamin C Group | Lowered significantly | Higher significantly |
| Combined Group (Resveratrol + Vitamin C) | Equal to Vitamin C Group | Lowered compared to Vitamin C only |
Notably, the combined treatment group noted a significant reduction of 33% in lipohydroperoxide (LPH) levels, compared to 25% and 15% in the resveratrol and vitamin C groups respectively. These differences may have lacked statistical significance due to a limited sample size, suggesting the need for further research.
Analysis of Lipid and Protein Damage
Measurement of malondialdehyde (MDA), an end product of lipid peroxidation, demonstrated reductions after treatment across all groups:
| Group | MDA Reduction (%) |
|---|---|
| Resveratrol Group | 26% |
| Combined Group | 32% |
| Vitamin C Group | 38% |
Moreover, a significant decrease in protein oxidative damage was recorded, with a reduction of 39% for the combined group and 29% for both the resveratrol and vitamin C groups.
No Impact on Insulin Resistance
Despite the favorable outcomes regarding oxidative stress, the study found no significant improvements in insulin resistance, which has been a topic of prior research linking oxidative state to insulin metabolic processes. Only one prior study showed any correlation between resveratrol and insulin resistance, leading to an ongoing debate regarding the effectiveness of resveratrol in this context.
Limitations and Conclusion
The authors of the study caution against over-interpreting the results due to its limitations, including lack of a control group and a homogeneous sample made up solely of women from a specific geographic region. The conclusion drawn states that while oxidative stress markers improved, none of the supplement strategies were statistically superior, highlighting the need for future exploration with larger, varied populations to attain generalized insights.
Overall, these findings contribute to ongoing discussions about targeted supplementation to reduce oxidative stress in postmenopausal populations, paving the way for enhanced health interventions in this demographic.
Literature Cited
[1] Montoya-Estrada, A., et al. (2024). The Administration of Resveratrol and Vitamin C Reduces Oxidative Stress in Postmenopausal Women. Nutrients, 16(21), 3775.
[2] Montoya-Estrada, A., et al. (2020). Parameters of Oxidative Stress in Reproductive and Postmenopausal Mexican Women. International journal of environmental research and public health, 17(5), 1492.
[3] Breuss, J. M., et al. (2019). Resveratrol and Its Effects on the Vascular System. International journal of molecular sciences, 20(7), 1523.
[4] Xia, N., et al. (2017). Antioxidant effects of resveratrol in the cardiovascular system. British journal of pharmacology, 174(12), 1633–1646.
[5] Livraghi, V., et al. (2024). A proteasome-dependent inhibition of SIRT-1 by the resveratrol analogue 4,4′-dihydroxy-trans-stilbene. Journal of traditional and complementary medicine, 14(5), 534–543.
[6] Kong, D., et al. (2019). Effects of Resveratrol on the Mechanisms of Antioxidants and Estrogen in Alzheimer’s Disease. BioMed research international, 2019, 8983752.
[7] Ismy, J., et al. (2024). Role of antioxidants in reducing oxidative stress and seizure frequency in drug-resistant epileptic patients. Narra J, 4(2), e790.
[8] Lifespan.io
Discussion